Subscribe to our RSS feeds RSS | Login | Register  
 

Rx drug word-of-mouth occurs largely offline: study

Ben Comer July 11, 2008

Consumers engaging in prescription drug-related word-of-mouth tend to do it offline, according to a Keller Fay Group report.
 

PhRMA Code cracks down on gifts to docs

Matthew Arnold July 10, 2008

PhRMA revised its Code on Interactions with Healthcare Professionals to sharply limit gifts to physicians.
 

FDA consolidates drug application responses

Ben Comer July 09, 2008

The FDA will change the way it responds to drug applications, eliminating "approvable" and "not approvable" letters.
 

More docs using mobile devices: Manhattan Research

Ben Comer July 08, 2008

Mobile devices provide an increasing number of doctors with information and resources, from CME to drug reference databases, according to a Manhattan Research survey.
 

Novartis has eyes for Alcon

Matthew Arnold July 08, 2008

Novartis shelled out $10.4 billion to Nestle for a 25% stake in eye care company Alcon.
 

Chairman of LyonHeart announces retirement

Ben Comer July 07, 2008

Al Nickel, chairman of LyonHeart and the TBWA\WorldHealth network, has announced his retirement.
 

Eli Lilly most esteemed pharma company for psychiatrists: Verispan

Ben Comer July 03, 2008

Verispan's biennial study, Pharmaceutical Company Image 2008, found that Eli Lilly ranked highest with psychiatrists.
 

Pfizer sacks commercial support of CME

Matthew Arnold July 02, 2008

Pfizer will no longer fund continuing medical education through med ed firms.
 

Fed up Sermo docs draft manifesto

Matthew Arnold July 01, 2008

A physicians' manifesto of sorts, composed by Sermo doctors demanding an end to intrusive insurers and overzealous regulators, has garnered 5,200 signatures in the several weeks since it was posted.
 

Senator slaps GSK med ed in letter to ACCME

Matthew Arnold June 30, 2008

The chairman of the Senate Committee on Aging has written the Accreditation Council for Continuing Medical Education (ACCME) complaining that GlaxoSmithKline, which makes Valtrex, "sponsors CME events which promote testing all pregnant women for herpes."